Диссертация (1174321), страница 30
Текст из файла (страница 30)
Bunch, J.P. Weiss, B.G. Crandall, H.T. May, T. L. Bair,J.S. Osborn, J.D. Day / /Heart rhythm. – 2010. – Т. 7 – № 4. – С.433-437.152. Bushnell, C. D. Persistence with stroke prevention medications 3 months afterhospitalization / C.D. Bushnell, L.O. Zimmer, W. Pan, D.M. Olson, X. Zhao, T.Meteleva, E.D. Peterson // Archives of neurology. – 2010. – Т.
67 – №. 12. – С.14561463.153. Cacciatore, F. Congestive heart failure and cognitive impairment in an olderpopulation / F. Cacciatore, P. Abete, N. Ferrara, C. Calabrese, C. Napoli, S. Maggi //Journal of the American Geriatrics Society. – 1998. – Т. 46 – № 11. – С.1343-1348.154. Caratozzolo, S. Prestroke dementia: characteristics and clinical features inconsecutive series of patients / S. Caratozzolo, M.
Riva, B. Vicini Chilovi, E. Cerea,177G. Mombelli, A. Padovani, L. Rozzini // European neurology. – 2014. – Т. 71 – № 34. – С.148-154.155. Carlo, A. Cognitive impairment without dementia in older people: prevalence,vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging /A. Carlo, M. Baldereschi, L. Amaducci, S. Maggi, F. Grigoletto, G. Scarlato, D.Inzitari // Journal of the American Geriatrics Society. – 2000. – Т. 48 – № 7. – С.775782.156. Cervilla, J. A. Smoking, drinking, and incident cognitive impairment: a cohortcommunity based study included in the Gospel Oak project / J. A.
Cervilla, M. Prince,A. Mann // Journal of Neurology, Neurosurgery & Psychiatry. – 2000. – Т. 68 – № 5.– С.622-626.157. Chambers, J. A. “My doctor has changed my pills without telling me”: impact ofgeneric medication switches in stroke survivors / J.A. Chambers, R. E. O’Carroll, M.Dennis, C. Sudlow, M. Johnston // Journal of behavioral medicine. – 2014. – Т. 37 –№ 5.
– С.890-901.158. Cho, S.J. Post-stroke memory impairment among patients with vascular mildcognitive impairment / S.J. Cho, K.H. Yu, M.S. Oh, S. Jung, J. H. Lee, I. S. Koh, B.C.Lee // BMC neurology. – 2014. – Т. 14 – № 1. – С.244.159. Chuang, Y.F. Association between APOE ε4 allele and vascular dementia: TheCache County study / Y.F. Chuang, K.M. Hayden, M.C. Norton, J.
Tschanz, J.C.Breitner, K.A. Welsh-Bohmer // Dementia and geriatric cognitive disorders. – 2010.– Т. 29 – № 3. – С.248-253.160. Conn, V. Cognitive impairment and medication adherence / V. Conn, S. Taylor, R.Miller // Journal of gerontological nursing. – 1994. – Т. 20 – № 7. – С.41-47.161. Connor, J. Do fixed-dose combination pills or unit-of-use packaging improveadherence? A systematic review / J. Connor, N. Rafter, A. Rodgers // Bulletin of theWorld Health Organization. – 2004. – Т.
82 – № 12. – С.935-939.162. Cooper, C. The AdHOC Study of older adults' adherence to medication in 11countries / C. Cooper // The American journal of geriatric psychiatry. – 2005. – Т. 13– № 12. – С.1067-1076.178163. Cumming, T.B. Stroke, cognitive deficits, and rehabilitation: still an incompletepicture / T.B. Cumming, R.S. Marshall, R.M. Lazar // International Journal of Stroke.– 2013. – Т. 8 – № 1.
– С. 38-45.164. Demarin, V. Carotid artery disease and cognitive impairment / V. Demarin, I.Zavoreo, V.B. Kes //Journal of the neurological sciences. – 2012. – Т. 322 – № 1. –С. 107-111.165. Desmond, D.W. Frequency and clinical determinants of dementia after ischemicstroke / D.W. Desmond, J.T. Moroney, M.C. Paik, M. Sano, J.P. Mohr, S. Aboumatar,C.-L.
Tseng, S. Chan, J.B. W. Williams, R.H. Remien, W.A. Hauser, Y. Stern //Neurology. – 2000. – Т. 54 – № 5. – С.1124-1131.166. DiMatteo, M. R. Depression is a risk factor for noncompliance with medicaltreatment: meta-analysis of the effects of anxiety and depression on patient adherence/ M.R. DiMatteo, H.S. Lepper, T.W. Croghan //Archives of internal medicine. – 2000.– Т.
160 – № 14. – С.2101-2107.167. Dodson, J.A. Cognitive impairment in older adults with heart failure: prevalence,documentation, and impact on outcomes / J.A. Dodson, T.T.N. Truong, V.R. Towle,G. Kerins, S.I. Chaudhry // The American journal of medicine. – 2013. – Т. 126 – №2. – С.120-126.168. Douiri, A. Prevalence of poststroke cognitive impairment: South London strokeregister 1995–2010 / A. Douiri, A.G. Rudd, C.D.A. Wolfe // Stroke.
– 2013. – Т. 44 –№ 1. – С.138-145.169. Dubois, B. The FAB: a frontal assessment battery at bedside / B. Dubois, A.Slachevsky, I. Litvan, B. Pillon // Neurology. – 2000. – Т. 55 – № 11. – С.1621-1626.170. Duron, E. Hypertension, cognitive decline and dementia / E. Duron, O. Hanon//Archives of cardiovascular diseases. – 2008. – Т.
101 – №.3. – С.181-189.171. Ebady, S.A. Investigation on the relationship between diabetes mellitus type 2 andcognitive impairment / S.A. Ebady, M.A. Arami, M.H. Shafigh // Diabetes researchand clinical practice. – 2008. – Т. 82 – № 3. – С.305-309.172. Erkens, J.A. Differences in antihypertensive drug persistence associated with drugclass and gender: a PHARMO study / J.A. Erkens, M.M. Panneman, O.H. Klungel,179G.V.D. Boom, M.F. Prescott, R.M.
Herings // Pharmacoepidemiology and drug safety.– 2005. – Т. 14 – № 11. – С.795-803.173. Erkinjuntti, T. Cerebrovascular dementia / T. Erkinjuntti // CNS drugs. – 1999. –Т. 12 – № 1. – С. 35-48.174. Feigin, V.L. Global Burden of Stroke / V.L. Feigin, B. Norrving, G.A. Mensah //Circulation Research. – 2017. – Т. 120 – № 3. – С.439-448.175. Feigin, V. L. Global and regional burden of stroke during 1990–2010: findingsfrom the Global Burden of Disease Study 2010 / V.L. Feigin // The Lancet. – 2014. –Т. 383 – № 9913. – С.245-255.176. Firbank, M.J. Medial temporal atrophy rather than white matter hyperintensitiespredict cognitive decline in stroke survivors / M.
J. Firbank, E. J. Burton, R. Barber,S. Stephens, R.A. Kenny, C. Ballard, R.N. Kalaria, J.T. O’Brien // Neurobiology ofaging. – 2007. – Т. 28 – № 11. – С.1664-1669.177. Fodor, G.J. Is interview a reliable method to verify the compliance withantihypertensive therapy? An international central -European study / G.J. Fodor, M.Kotrec, K.
Bacskai, T. Dorner, J. Lietava, S. Sonkodi, P. Turton // Journal ofHypertension. – 2005. – Т. 23 – № 6. – С.1261-1266.178. Fratiglioni, L. Incidence of dementia and major subtypes in Europe: Acollaborative study of population-based cohorts. Neurologic Diseases in the ElderlyResearch Group / L. Fratiglioni, L.J. Lauper, K. Andersen, M. M. Breteler, J.R.Copeland, J.F. Dartigues, A. Lobo, J. Martinez-Lage, H. Soininen, A. Hofman //Neurology.
– 2000. – Т. 54 – № 11. – С.10-15.179. Gehi, A. Depression and medication adherence in outpatients with coronary heartdisease: findings from the Heart and Soul Study / A. Gehi, D. Haas, S. Pipkin, M.A.Whooley //Archives of internal medicine. – 2005. – Т. 165 – № 21. – С.2508-2513.180. Glader, E.L.
Persistent use of secondary preventive drugs declines rapidly duringthe first 2 years after stroke / E.L. Glader, M. Sjölander, M. Eriksson, M. Lundberg //Stroke. – 2010. – Т. 41 – № 2. – С.397-401.181. Goldstein, L.B. Interrater reliability of the NIH stroke scale / L.B. Goldstein, C.Bertels, J.N.
Davis //Archives of neurology. – 1989. – Т. 46 – № 6. – С.660-662.180182. Gorelick, P.B. Vascular contributions to cognitive impairment and dementia: astatement for healthcare professionals from the American Heart Association/ P. B.Gorelick, A. Scuteri, S.E. Black, C. DeCarli, S.M. Greenberg, C.
Iadecola, L.J.Launer, S. Laurent, O.L. Lopez, D. Nyenhuis, R.C. Petersen, J.A. Schneider, C.Tzourio, D.K. Arnett, D.A. Bennett, H.C. Chui, R.T. Higashida, R. Lindquist, P. M.Nilsson, G.C. Roman, F.W. Sellke, S. Seshadri // Stroke. – 2011. – Т. 42 – № 9. –С.2672-2713.183. Gorelick, P.B. Status of risk factors for dementia associated with stroke / P.B.Gorelick // Stroke. – 1997. – Т.
28 – № 2. – С.459-463.184. Granger, B.B. Adherence to medication according to sex and age in the CHARMprogramme / B.B. Granger, I. Ekman, C.B. Granger, J. Ostergren, B. Olofsson, E.Michelson, J.V.J. McMurray, S. Yusuf, M.A. Pfeffer, K. Swedberg // Europeanjournal of heart failure. – 2009. – Т.
11 – № 11. – С.1092-1098.185. Grant, R.W. Polypharmacy and medication adherence in patients with type 2diabetes / R.W. Grant, N.G. Devita, D.E. Singer, J.B. Meigs // Diabetes care. – 2003.– Т. 26 – № 5. – С.1408-1412.186. Gray, S.L. Medication adherence in elderly patients receiving home health servicesfollowing hospital discharge / S L. Gray, J.E. Mahoney, D.K. Blough //Annals ofPharmacotherapy.
– 2001. – Т. 35 – № 5. – С.539-545.187. Guercini, F. Cryptogenic stroke: time to determine aetiology / F. Guercini, M.Acciarresi, G. Agnelli, M. Paciaroni // Journal of Thrombosis and Haemostasis. –2008. – Т. 6 – № 4. – С.549-554.188. Gunstad, J. Longitudinal examination of obesity and cognitive function: resultsfrom the Baltimore longitudinal study of aging / J. Gunstad, A. Lhotsky, C.R. Wendell,L. Ferrucci, A.B. Zonderman // Neuroepidemiology. – 2010. – Т. 34 – № 4.
– С.222229.189. Gutiérrez Pérez, C. High frequency of cognitive dysfunction before stroke amongolder people / C.G. Pérez, M. Sävborg, U. Påhlman, M. Cederfeldt, E. Knopp, A.Nordlund, E. Tarkowski // International journal of geriatric psychiatry. – 2011. – Т.26 – № 6. – С.622-629.181190.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
